Seminars in Oncology
Volume 30, Issue 3 , Pages 369-374, June 2003

Close monitoring and lifetime follow-up is optimal for patients with a history of melanoma

  • David F. Christianson

      Affiliations

    • Department of Internal Medicine, University of Missouri Health Care, Ellis Fischel Cancer Center, Columbia, MO, USA
    • ,
  • Clay M. Anderson

      Affiliations

    • Department of Internal Medicine, University of Missouri Health Care, Ellis Fischel Cancer Center, Columbia, MO, USA
    • *Address reprint requests to Clay Anderson, MD, Department of Internal Medicine-Hematology/Oncology, University of Missouri Health Care, Ellis Fischel Cancer Center, Business Loop 70 West, Columbia, MO 65203 USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(03)00097-6

Seminars in Oncology
Volume 30, Issue 3 , Pages 369-374, June 2003

Article Tools